QLTY

GMO U.S. Quality ETF

OtherPSEGMO ETF
$43.41
$0.32 (+0.74%)
Delayed ≥20 min · Aug 13, 2026

Key Statistics

Net Assets (AUM)
$3.49B
Expense Ratio
See prospectus
Previous Close
$43.09
Day Range
- – -
52-Week Range
$34.36 – $43.40
Volume
310.50K
Avg Vol (50D)
-
Beta
0.96

Historical Performance

1M
+4.15%
3M
+7.04%
6M
+13.26%
YTD
+13.26%
1Y
+26.01%
3Y
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Lam Research Corp 5.35%
Microsoft Corp 5.34%
Alphabet Inc 5.32%
Johnson & Johnson 4.93%
Meta Platforms Inc 4.70%
Apple Inc 4.50%
KLA Corp 4.21%
Broadcom Inc 3.93%
Salesforce Inc 3.53%
Texas Instruments Inc 3.36%
Thermo Fisher Scientific Inc 3.30%
Accenture PLC 3.29%
Abbott Laboratories 3.20%
Eli Lilly & Co 3.18%
Amazon.com Inc 3.11%
Hilton Worldwide Holdings Inc 2.96%
Procter & Gamble Co/The 2.90%
US Bancorp 2.60%
UnitedHealth Group Inc 2.33%
Visa Inc 2.21%
Aramark 2.07%
Elevance Health Inc 2.05%
Merck & Co Inc 2.02%
Coca-Cola Co/The 1.93%
Constellation Brands Inc 1.85%

Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About QLTY

The Fund is an actively managed exchange-tradedfund (“ETF”) that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that theFund’s adviser, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO” or the “Adviser”), believes to beof high quality. GMO believes a high quality company generally to be a company that has an established business that will deliver a highlevel of return on past investments and that will use cash flows to make investments with the potential for a high return on capitalor to return cash to shareholders through dividends or share buybacks. Equity securities primarily include common and preferred stocksand, to a lesser extent, other stock-related securities, such as convertible securities, depositary receipts, equity real estate investmenttrusts (“REITs”), income trusts, and securities of other investment companies that investment primarily in equity securities. In selecting securities for purchase and saleby the Fund, GMO uses a combination of investment methods, typically considering both (1) systematic factors, based on profitability,profit stability, leverage, and other publicly available financial information, and (2) judgmental factors, based on GMO’sassessment of future profitability, capital allocation, growth opportunities, and sustainability against competitive forces. The weightthat each systematic and judgmental factor is given for a particular security varies over time and depends on GMO’s assessmentof the factor’s materiality and relevance to that security. GMO also may rely on valuation methodologies, such as discounted cashflow analysis and multiples of price to earnings, revenues, book values or other fundamental metrics with the objective of buying higherquality stocks at a discount to what GMO believes to be their fundamental fair (or intrinsic) value. The Fund is not subject to any limiton the frequency with which portfolio securities may be purchased or sold, and GMO makes investment decisions for the Fund without regardto portfolio turnover rates. At times, the Fund may have substantial exposureto a single asset class, industry, sector, issuer, or companies with similar market capitalizations. The Fund may invest in securitiesof companies of any market capitalization. The factors GMO considers and investment methods GMO uses can change over time. GMO does notmanage the Fund to, or control the Fund’s risk relative to, any securities index or securities benchmark. As an alternative to investing directly inequities or in an attempt to obtain or adjust elements of its investment exposure, the Fund may invest in other ETFs. Undernormal circumstances, the Fund invests directly and indirectly (e.g., through underlying funds) at least 80% of its assetsin companies tied economically to the United States (the “Name Policy”). The Fund also may invest in the GMO U.S. TreasuryFund, a mutual fund advised by GMO, or in money market funds unaffiliated with GMO, and directly in the types of investments typicallyheld by money market funds.

Data for QLTY is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.